1. United Nations. Convention on Psychotropic substances, 1971 [Internet]. Vienna; 1971. Accessed 26 Jun 2021. https://www.unodc.org/pdf/convention_1971_en.pdf
2. Abuhasira R, Shbiro L, Landschaft Y. Medical use of cannabis and cannabinoids containing products—regulations in Europe and North America. Eur J Intern Med. 2018;49:2–6.
3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Medical use of cannabis and cannabinoids: questions and answers for policymaking : December 2018. Luxembourg: Publication Office of the European Union; 2018.
4. EMCDDA. Monitoring and evaluating changes in cannabis policies: insights from the Americas. [Internet]. LU: Publications Office; 2020. Accessed 26 Jun 2021. https://data.europa.eu/doi/10.2810/151487
5. Bridgeman MB, Abazia DT. Medicinal Cannabis: history, pharmacology, and implications for the acute care setting. Pharm Ther. 2017;42:180–8.